Global therapeutic market is witnessing lot of activities with many therapies transitioning to phase 3 studies, wherein they are being tested on large group of individuals while many other are awaiting commercial launch. Broadly, on the basis of different human systems and diseases associated with them, therapeutic areas can be segmented into neurological diseases, oncology, gastrointestinal diseases, infectious diseases, cardiovascular diseases, inflammatory diseases and haematological diseases. Of these therapeutic classes, oncology is the biggest revenue generating segment and it is associated with cure of various types of cancers such as lung, stomach, breast, liver, cervical, oesophageal, bladder, colon and prostate. Based on technology, cancer therapeutics market can be segmented into chemotherapy, hormone therapy, biotherapy and radiation therapy.
Spending on medicines for different diseases and therapeutic areas varies significantly between developed and pharmerging markets. Considering the ageing population and obesity in developed countries, diseases like cancer and diabetes are likely to drive the major spending; although, pharmerging market is also expected to witness the same trend in future. In developed markets, speciality pharmaceuticals which are used to treat complex and serious diseases in hospitals, is gaining traction; however, traditional therapy areas are going to drive the overall spending in different therapeutic areas.
Increasing awareness, aging population and growing overall income status & lifestyle in developed and many pharmerging countries are driving the growth of therapeutic areas. Infectious disease therapeutic market has witnessed uptick in recent time majorly due to increase in infectious diseases. Increasing awareness programs and growth of interferon free dosing regimens are some of the new trends emerging in the Infectious disease therapeutics market.
Liver disease therapeutics market growth is majorly expedited by strong drug pipeline and increasing expenditure by pharmaceutical and biotechnology companies.
ASDReport.com provides an extensive coverage on most of the disease & therapeutic areas wherein the reports provide market insights on various diseases and associated treatments like, Alzheimer’s disease, prostate cancer, pain management, infection surveillance, and much more.
Depression Drugs Market - Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024
Feb 2017
|
US$ 4,995.00
US$ 4,995.00
The Global Anti-Inflammatory Therapeutics Market Forecast 2017-2027
Jun 2017
|
US$ 3,249.00
US$ 3,249.00
Global Respiratory Diagnostics Market Report 2017-2027
Jun 2017
|
US$ 3,249.00
US$ 3,249.00
Leukemia Diagnostic Tests - Medical Devices Pipeline Assessment, 2017
Jun 2017
|
US$ 4,000.00
US$ 4,000.00
Prosthetic Heart Valve/ Artificial Heart Valve Market - Global Forecast to 2022
Jun 2017
|
US$ 5,650.00
US$ 5,650.00
Global Wound Cleanser Products Market - Analysis & Forecasts, 2016-2023
Jun 2017
|
US$ 3,599.00
US$ 3,599.00
EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2026
Jun 2017
|
US$ 3,995.00
US$ 3,995.00
EpiCast Report: Venous Thromboembolism - Epidemiology Forecast to 2026
Jun 2017
|
US$ 3,995.00
US$ 3,995.00
Global Anti-Epilepsy Drugs Market Forecast 2017-2027
May 2017
|
US$ 3,249.00
US$ 3,249.00
Next-Generation Cancer Diagnostics Market Forecast 2017-2027
May 2017
|
US$ 3,249.00
US$ 3,249.00
Global Erythropoietin Market Forecast 2017-2027
Apr 2017
|
US$ 3,249.00
US$ 3,249.00
Global Lymphoma Drugs Market 2017-2021
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Global Bladder Cancer Therapeutics Market 2017-2021
May 2017
|
US$ 3,500.00
US$ 3,500.00
Bromodomain Testis Specific Protein (Cancer/Testis Antigen 9 or RING3 Like Protein or BRDT) - Pipeline Review, H1 2017
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H1 2...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A4 Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H1 201...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Caspase 6 (Apoptotic Protease Mch 2 or CASP6 or EC 3.4.22.59) - Pipeline Review, H1 2017
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Granzyme B (C11 or CTLA 1 or Cathepsin G Like 1 or Cytotoxic T Lymphocyte Proteinase 2 or Fragmentin 2 or Granzyme 2 or ...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) ...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase o...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H1 2017
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Histone Lysine N Methyltransferase EHMT2 (Euchromatic Histone Lysine N Methyltransferase 2 or Histone H3 K9 Methyltransf...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Histone Lysine N Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) - Pipeline Review, H1 2017
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Serine/Threonine Protein Kinase ATR (Ataxia Telangiectasia And Rad3 Related Protein or FRAP Related Protein 1 or ATR or ...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosi...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Cell Division Protein FtsZ (ftsz) - Pipeline Review, H1 2017
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Dystrophin (DMD) - Pipeline Review, H1 2017
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Prote...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H1 2017
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H1 2017
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) - Pipeline Re...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Integrin Alpha 7 (ITGA7) - Pipeline Review, H1 2017
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Se...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Pipeline ...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Gr...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobu...
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) - Pipeline Review, H1 2017
Jun 2017
|
US$ 3,500.00
US$ 3,500.00
